6th Cancer Cachexia Conference 
August 27-29, 2021

Organizing Committee


Denis C. Guttridge, Chair
Denis C. Guttridge, Ph.D. is a Professor in the Department of Pediatrics at the Medical University of South Carolina (MUSC). He serves as Associate Director of Translational Sciences at the Hollings Cancer Center at MUSC. He currently serves as the President of the Cancer Cachexia Society. His areas of expertise are in NF-κB signaling and the regulation of skeletal myogenesis and muscle disorders. He served as the lead organizer of the 1st-5th Cancer Cachexia Conferences and has also chaired the Gordon conference on Myogenesis.

Marie Fallon, Co-Chair
Marie Fallon, M.D. is a Professor and Chair of Palliative Medicine and Supportive Care, at the University of Edinburgh, UK. She is based in the Edinburgh Cancer Centre where her clinical practice is tertiary referral of complex symptoms. She leads a translational research program in cancer pain and has a portfolio of clinical trials addressing challenging symptoms, including cancer cachexia, breathlessness and cancer pain. She is funded from NIHR, CRUK, MRC and the Marie Curie foundation. She has organized several international conferences on a number of cancer symptom related topics and chaired the scientific committees for the EAPC World Research Congresses, including the 2020 Palermo congress.

Imed Gallouzi, Co-Chair
Imed Gallouzi, Ph.D. is a Professor and Associate Chair in the Biochemistry Department and at the Goodman Cancer Center, at McGill University. His main research interests are focused on muscle fiber formation and muscle related diseases such as cancer cachexia. His recent contribution to the field opened the door to establish a link between posttranscriptional regulation of gene expression and the onset of cancer cachexia. He held a Canada Research Chair in cellular information from 2002 to 2012 and he is a panel member of several national and international granting agencies. He has been involved in organizing several international meetings in the field of posttranscriptional regulation of gene expression and their link to diseases such as cancer.

Andrew R. Judge, Co-Chair
Andrew Judge, PhD is an Associate Professor in the Department of Physical Therapy. Dr. Judge’s research is focused on understanding the molecular signaling pathways leading to skeletal muscle atrophy caused by disuse (cast immobilization), disease (cancer and peripheral arterial disease), sepsis and aging. In addition, ongoing work in his lab seeks to understand the role that specific proteins play in regulating muscle regrowth following atrophying conditions.

Stein Kaasa, Co-Chair
Stein Kaasa, MD, PhD is Professor of Palliative Medicine at the University of Oslo, Norway. His responsibilities include the development of the core curriculum in palliative medicine and the development of the Nordic specialist postgraduate training curriculum in palliative medicine. Professor Kaasa’s main research interests are: basic research in assessment and classification of symptoms and subjective health; experimental and descriptive clinical studies in palliative medicine and cancer research; pain treatment including translational research on opioids and on cachexia.

Teresa A. Zimmers, Co-Chair
Teresa Zimmers, Ph. D. is Professor of Surgery at the Indiana University School of Medicine. She directs the Cachexia Working Group and co-directs the Pancreatic Cancer Working Group of the IU Simon Comprehensive Cancer Center and the interdisciplinary IUPUI Center for Cachexia Research, Innovation, and Therapy. Her research centers on the systemic effects of cancer, particularly secreted protein mediators, and for several years she has focused primarily on pre-clinical and translational studies in pancreatic cancer. She served on the Scientific Conference Committee for the 2nd Cancer Cachexia Conference in 2014 and was a co-organizer for the 3rd, 4th and 5th Cancer Cachexia Conferences in 2016, 2018 and 2020.